Contact
Please use this form to send email to PR contact of this press release:
Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs
TO:
Please use this form to send email to PR contact of this press release:
Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs
TO: